Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.01 | 2.02 |
NAV | ₹10.72 | ₹404.52 |
Fund Started | 07 Oct 2024 | 01 Aug 2005 |
Fund Size | ₹2211.33 Cr | ₹2904.35 Cr |
Exit Load | 0.5% for redemption within 90 Days | Exit load of 1% if redeemed less than 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 4.70% | 2.29% |
3 Year | - | 13.14% |
5 Year | - | 14.04% |
1 Year
3 Year
5 Year
Equity | 99.26% | 98.52% |
Cash | 0.74% | 1.11% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Maruti Suzuki India Ltd. | 9.81% |
Britannia Industries Ltd. | 7.13% |
Hindustan Unilever Ltd. | 6.13% |
Nestle India Ltd. | 3.85% |
Vedanta Ltd. | 3.35% |
Acutaas Chemicals Ltd. | 3.12% |
GE Vernova T&D India Ltd | 2.92% |
United Spirits Ltd. | 2.85% |
Oracle Financial Services Software Ltd. | 2.75% |
JB Chemicals & Pharmaceuticals Ltd. | 2.74% |
Name | Assets |
|---|---|
Maruti Suzuki India Ltd. | 9.47% |
Procter & Gamble Health Ltd. | 5.11% |
Nestle India Ltd. | 4.90% |
Britannia Industries Ltd. | 4.52% |
Vedanta Ltd. | 4.39% |
United Spirits Ltd. | 4.36% |
Hindustan Unilever Ltd. | 4.23% |
Infosys Ltd. | 2.91% |
Gland Pharma Ltd. | 2.82% |
3M India Ltd. | 2.75% |
Name | Harsha Upadhyaya | Karthikraj Lakshmanan |
Start Date | 03 Apr 2025 | 29 Apr 2025 |
Name
Start Date
Description | The scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC). | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of multinational companies. |
Launch Date | 07 Oct 2024 | 01 Aug 2005 |
Description
Launch Date